Tourmaline Bio(US:TRML) Prnewswire·2025-09-15 21:30Core Viewpoint - Class Action Attorney Juan Monteverde and his firm, Monteverde & Associates PC, are investigating the proposed sale of Tourmaline Bio, Inc. to Novartis AG, where shareholders are set to receive $48.00 in cash per share, raising questions about the fairness of the deal [1]. Group 1 - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has successfully recovered millions for shareholders [1]. - The firm is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2]. - The investigation into Tourmaline Bio, Inc. is part of the firm's broader efforts to ensure fair treatment for shareholders in significant corporate transactions [1][2]. Group 2 - The firm encourages shareholders with concerns regarding the transaction to reach out for additional information at no cost [2]. - Monteverde & Associates PC has a successful track record in trial and appellate courts, including the U.S. Supreme Court, emphasizing their legal expertise [2]. - The firm is also involved in other investigations, indicating a proactive approach to shareholder rights [4].